株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

冠動脈血栓症:世界の臨床試験レビュー(2011年下半期)

Coronary Thrombosis Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 217237
出版日 ページ情報 英文 38 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.63円で換算しております。
Back to Top
冠動脈血栓症:世界の臨床試験レビュー(2011年下半期) Coronary Thrombosis Global Clinical Trials Review, H2, 2017
出版日: 2017年07月19日 ページ情報: 英文 38 Pages
概要

当レポートでは、冠動脈血栓症治療薬の臨床試験におけるデータを提供、国別の動向、臨床試験数、世界における臨床実験所別の募集状況などをまとめ、概略以下の構成でお届けします。

目次

イントロダクション

  • 冠動脈血栓症
  • 本レポートについて

地域別の臨床試験

  • 国別臨床試験
    • アジア太平洋における上位国
    • 欧州における上位5か国
    • 北米における上位国

G7諸国における臨床試験

進捗状況別:G7諸国における臨床試験

相別の臨床試験

進捗状況別の臨床試験

未達成の臨床試験

一定期間に採用された被験者

有望なスポンサー

有望な薬剤の比較

臨床試験プロファイル

  • 臨床試験概要:上位企業
    • Abbott Laboratories
  • 臨床試験概要:上位大学・研究所・病院
    • Scripps Health
    • Minneapolis Medical Research Foundation
    • Heart Center Bad Krozingen
    • University Hospital Gasthuisberg
    • University of Zurich
    • Samsung Medical Center
    • The University of Hong Kong
    • University Hospital Basel
    • Assistance Publique - Hopitaux de Paris

5つの主な臨床プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4342CTIDB

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Coronary Thrombosis Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 36

  • Abbreviations 36
  • Definitions 36
  • Research Methodology 37
  • Secondary Research 37
  • About GlobalData 38
  • Contact Us 38
  • Source 38

List of Tables

List of Tables

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Coronary Thrombosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 37
Back to Top